Gregory J. Gores
Gregory J. Gores
Verified email at
Cited by
Cited by
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
Mechanisms of hepatotoxicity
H Jaeschke, GJ Gores, AI Cederbaum, JA Hinson, D Pessayre, ...
Toxicological sciences 65 (2), 166-176, 2002
A global view of hepatocellular carcinoma: trends, risk, prevention and management
JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts
Nature reviews Gastroenterology & hepatology 16 (10), 589-604, 2019
N Razumilava, GJ Gores
The Lancet 383 (9935), 2168-2179, 2014
Diagnosis and management of primary sclerosing cholangitis
R Chapman, J Fevery, A Kalloo, DM Nagorney, KM Boberg, B Shneider, ...
Hepatology 51 (2), 660-678, 2010
Hepatocellular carcinoma: clinical frontiers and perspectives
J Bruix, GJ Gores, V Mazzaferro
Gut 63 (5), 844-855, 2014
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ...
Gastroenterology 125 (2), 437-443, 2003
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
J Bridgewater, PR Galle, SA Khan, JM Llovet, JW Park, T Patel, TM Pawlik, ...
Journal of hepatology 60 (6), 1268-1289, 2014
Biliary tract cancers
PC De Groen, GJ Gores, NF LaRusso, LL Gunderson, DM Nagorney
New England Journal of Medicine 341 (18), 1368-1378, 1999
Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway
AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ...
Hepatology 40 (1), 185-194, 2004
mir-29 regulates Mcl-1 protein expression and apoptosis
JL Mott, S Kobayashi, SF Bronk, GJ Gores
Oncogene 26 (42), 6133-6140, 2007
Pathogenesis, diagnosis, and management of cholangiocarcinoma
S Rizvi, GJ Gores
Gastroenterology 145 (6), 1215-1229, 2013
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
PA Clavien, M Lesurtel, PMM Bossuyt, GJ Gores, B Langer, A Perrier
The lancet oncology 13 (1), e11-e22, 2012
Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: a pilot study
J Laurin, KD Lindor, JS Crippin, A Gossard, GJ Gores, J Ludwig, J Rakela, ...
Hepatology 23 (6), 1464-1467, 1996
Apoptosis and necrosis in the liver: a tale of two deaths?
H Malhi, GJ Gores, JJ Lemasters
Hepatology 43 (S1), S31-S44, 2006
Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c
ME Guicciardi, J Deussing, H Miyoshi, SF Bronk, PA Svingen, C Peters, ...
The Journal of clinical investigation 106 (9), 1127-1137, 2000
Lysosomes in cell death
ME Guicciardi, M Leist, GJ Gores
Oncogene 23 (16), 2881-2890, 2004
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
M Jaiswal, NF LaRusso, LJ Burgart, GJ Gores
Cancer research 60 (1), 184-190, 2000
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment
B Blechacz, GJ Gores
Hepatology (Baltimore, Md.) 48 (1), 308, 2008
Cholangiocarcinoma—evolving concepts and therapeutic strategies
S Rizvi, SA Khan, CL Hallemeier, RK Kelley, GJ Gores
Nature reviews Clinical oncology 15 (2), 95-111, 2018
The system can't perform the operation now. Try again later.
Articles 1–20